Algeria vs India: Average cost of tuberculosis treatment multi drug resistant
Algeria
440
in 2022
India
400
in 2024
Algeria rank
85th
India rank
87th
Average cost of tuberculosis treatment multi drug resistant over time
- Algeria
- India
How they compare
Algeria currently reports 440 against 400 in India, a difference of 40.
That makes Algeria's figure about 1.1 times India's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was India ahead.
Algeria ranks 85th and India ranks 87th of 92 countries.
Across the 2 decades both report, Algeria averaged higher in 1 and India in 1.
Head to head by decade
| Decade | Algeria | India | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 862.5 | 1,650 | 787.5 | India |
| 2020s | 680 | 472 | 208 | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of tuberculosis treatment multi drug resistant, Algeria or India?
- Algeria, at 440 against 400 in India as of 2022.
- What is the difference in average cost of tuberculosis treatment multi drug resistant between Algeria and India?
- 40, with Algeria ahead.
- How many years of comparable data are there for Algeria and India?
- 5 years are reported by both, from 2017 to 2022.
- How do Algeria and India rank globally for average cost of tuberculosis treatment multi drug resistant?
- Algeria ranks 85th and India ranks 87th of 92 countries.
- Where does this data come from?
- Our World in Data, published as Average cost of tuberculosis treatment multi drug resistant. Statizoid refreshes it automatically from the source and publishes the full history for both places.